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Effects of flax supplementation and a Revalor-S implant on circulating insulin-like
growth factor 1 (IGF-1) and muscle IGF-1 mRNA levels in finishing cattle
Abstract
Sixteen crossbred steers weighing 875 lb were used to evaluate the effects of a 5% ground flaxseed
supplement and a combined trenbolone acetate/estradiol (TBA/E2) growth promoting implant, RevalorS®, on both circulating insulin-like growth factor-1 (IGF-1) and local muscle IGF-1 mRNA concentrations.
Steers were randomly assigned to one of four treatments: . 1) Flax/Implant, 2) No Flax/ Implant, 3) Flax/
No Implant, 4) No Flax/No Implant. Serum was harvested from blood collected via jugular venipuncture
on day 0 (before implantation or flax addition), 14, and 28. Muscle biopsy samples were obtained from the
longissimus muscle on days 0, 14, and 28. Implanted steers had 52 and 84% higher (P<0.05) circulating
IGF-1 levels than non-implanted steers on days 14 and 28, respectively. Cattle fed diets without flax had
higher levels of muscle IGF-1 mRNA than cattle fed diets with flax on day 28 (4.4-fold, P<0.01). Our data
support that the administration of a combined TBA/E2 growth promotant increases circulating IGF-1 and
local muscle IGF-1 mRNA concentrations in finishing cattle. However, this increase in muscle IGF-1 mRNA
appears to be attenuated by the addition of a dietary flax supplement.
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EFFECTS OF FLAX SUPPLEMENTATION AND A REVALOR-S IMPLANT ON
CIRCULATING INSULIN-LIKE GROWTH FACTOR 1 (IGF-1) AND
MUSCLE IGF-1 mRNA LEVELS IN FINISHING CATTLE
J. D. Dunn, J. P. Kayser, A. T. Waylan, E. K. Sissom,
J. S. Drouillard, and B. J. Johnson
ishing cattle. IGF-1 is a very important growth
factor for skeletal muscle growth because it
stimulates muscle cell proliferation, differentiation, and protein synthesis. Flaxseed is a
source of alpha-linolenic acid, which is an
omega-3 polyunsaturated fatty acid. Additions of dietary omega-3 fatty acids have been
shown to increase cell membrane fluidity,
which may enhance the ability of IGF-1 to
bind to its receptor in muscle tissue, thus potentiating IGF-1 actions in muscle. There is
potential for additive or synergistic effects on
muscle growth when growth promotants that
increase both circulating IGF-1 and muscle
IGF-1 mRNA concentrations are used in conjunction with feedstuffs high in omega-3 fatty
acids. The objective of our study was to determine how circulating IGF-1 and muscle
IGF-1 mRNA levels are affected by a 5%
ground flaxseed supplement and administration of a combined TBA/E2 implant, RevalorS.

Summary
Sixteen crossbred steers weighing 875 lb
were used to evaluate the effects of a 5%
ground flaxseed supplement and a combined
trenbolone acetate/estradiol (TBA/E2) growth
promoting implant, Revalor-S®, on both circulating insulin-like growth factor-1 (IGF-1) and
local muscle IGF-1 mRNA concentrations.
Steers were randomly assigned to one of four
treatments: . 1) Flax/Implant, 2) No Flax/ Implant, 3) Flax/No Implant, 4) No Flax/No Implant. Serum was harvested from blood collected via jugular venipuncture on day 0 (before implantation or flax addition), 14, and 28.
Muscle biopsy samples were obtained from
the longissimus muscle on days 0, 14, and 28.
Implanted steers had 52 and 84% higher
(P<0.05) circulating IGF-1 levels than nonimplanted steers on days 14 and 28, respectively. Cattle fed diets without flax had higher
levels of muscle IGF-1 mRNA than cattle fed
diets with flax on day 28 (4.4-fold, P<0.01).
Our data support that the administration of a
combined TBA/E2 growth promotant increases circulating IGF-1 and local muscle
IGF-1 mRNA concentrations in finishing cattle. However, this increase in muscle IGF-1
mRNA appears to be attenuated by the addition of a dietary flax supplement.

Experimental Procedures
Sixteen crossbred steers weighing 875 lb
were stratified by weight and randomly assigned to one of four treatments:
1)
Flax/Implant, 2) No Flax/Implant, 3) Flax/No
Implant, 4) No Flax/No Implant. Steers were
allowed ad libitum access to a 92% concentrate diet supplied once daily (Table 1). Serum was harvested from blood samples collected by jugular venipuncture on days 0 (before implantation and flax addition), 14, and
28 and were stored for subsequent analysis of
circulating IGF-1. Muscle biopsy samples
were obtained from the longissimus dorsi on

Introduction
Growth promoting implants containing
both trenbolone acetate (TBA) and estradiol
(E2) are known to increase insulin-like growth
factor-1 (IGF-1) levels in circulation as well
as IGF-1 mRNA levels in the muscle of fin199

Revalor-S, increased circulating IGF-1 and
muscle IGF-1 mRNA levels in finishing cattle.

days 0, 14, and 28 using a Bergstrom biopsy
needle. Total RNA was isolated from the
muscle samples, and real-time quantitative
polymerase chain reaction (PCR) was used to
evaluate IGF-1 gene expression.

Flax supplementation had no effect on circulating IGF-1 levels, and it led to lower muscle IGF-1 mRNA levels on day 28 (Figure 2).
It is possible that the addition of flax to the
diet increased the sensitivity of the muscle tissue to systemic IGF-1, which could, in turn,
cause the level of muscle IGF-1 gene expression to be down-regulated. It is also possible
that the alpha-linolenic acid in the flax supplement had direct effects on muscle IGF-1
gene expression. It is not possible to discern
from our data whether dietary addition of flax
has a direct or indirect effect on muscle IGF-1
mRNA levels. However, our data still offer
useful information toward the ultimate goal of
understanding how dietary additions of
omega-3 fatty acids and the use of anabolic
steroid implants impact muscle growth of finishing cattle.

Results and Discussion
Flax supplementation had no significant
effect on circulating IGF-1 levels in finishing
steers (Figure 1). Implanted steers had 52 and
84% greater (P<0.05) circulating IGF-1 levels
than their non-implanted counterparts on days
14 and 28, respectively (Figure 1). Cattle that
were not supplemented with flax had higher
(4.4 fold, P<0.01) levels of muscle IGF-1
mRNA on day 28 than those that received the
flax supplement. On day 28, implanted steers
had 2.4-fold higher (P<0.01) muscle IGF-1
mRNA levels than non-implanted steers (Figure 2). Our data was consistent with other research findings and demonstrates that the administration of a TBA/E2 growth promotant,
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Figure 1. Effect of Flax Supplementation and a Revalor-S Implant on Circulating IGF-1
Levels of Finishing Cattle.
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Figure 2. Effects of Flax Supplementation (Panel A) and a Revalor-S Implant (Panel B) on
Muscle IGF-1 mRNA Levels of Finishing Cattle.
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Table 1. Experimental Diets
Treatments
Ingredient

Flax
No Flax
------------ % of Dry Matter -----------77.5
81.9
5.9
5.9
8.0
8.0
5.1

3.6
4.2

Steam-flaked corn
Corn steep liquor
Alfalfa hay
Flaxseed, ground
Vitamin/trace mineral premixa

----------- lb per Steer Daily ----------0.5
0.5

b

Rumensin/Tylan premix
a

Vitamin/trace mineral premix formulated to provide (total diet dry matter): 1,500 IU/lb vitamin
A, 835 IU/lb vitamin E, 0.2 ppm cobalt, 13 ppm copper, 75 ppm manganese, 0.30 ppm selenium,
75 ppm zinc, and 78 ppm iodine.
b
Provided 300 mg Rumensin and 90 mg Tylan per steer daily.
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